Two drugmakers, Pfizer and Moderna, have announced promising interim results for their vaccine candidates, raising hopes that the end of the pandemic may be in sight. But, if and when the vaccines are authorized by the Food and Drug Administration, distributing them presents a daunting challenge, reports NPR.